Description
Provided is a monoclonal antibodies combing and inhibiting activation of epidermal growth factor relevant members Erbb3/HER3. The antibodies can be used for treating the esophagus cancer.
Target
ERBB3
Target Alias Names
Erb-B2 Receptor Tyrosine Kinase 3, V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3, Tyrosine Kinase-Type Cell Surface Receptor HER3, Human Epidermal Growth Factor Receptor 3, Proto-Oncogene-Like Protein C-ErbB-3, EC 2.7.10.1, HER3, Lethal Congenital Contracture Syndrome 2, Receptor Tyrosine-Protein Kinase ErbB-3, P180-ErbB3
Isotypes/Mimetics
Humanized IgG2, κ
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression